Yuehong Yang

发表

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus

J. Schleutker, T. Tammela, Liang Wang, 2018, Cell.

Gene regulatory mechanisms underpinning prostate cancer susceptibility

J. Lindberg, H. Grönberg, I. Mills, 2016, Nature Genetics.

Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG

Chaofu Wang, Yijun Tian, Qin Zhang, 2022, Nature Communications.

Chromatin interactions and candidate genes at ten prostate cancer risk loci

S. Thibodeau, Tiezheng Yuan, Meijun Du, 2016, Scientific Reports.

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding

Kai Zhang, Matti Nykter, Fredrik Wiklund, 2014, Nature Genetics.

Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.

Huanming Yang, Hancheng Zheng, Xiuqing Zhang, 2017, European urology.

Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression

J. Schleutker, Jianfeng Xu, Z. Mo, 2017, Scientific Reports.

Extensive germline-somatic interplay drives prostate cancer through HNF1B co-option of TMPRSS2-ERG

Liang Wang, Yijun Tian, Qin Zhang, 2021, bioRxiv.

Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression

J. Schleutker, Jianfeng Xu, Z. Mo, 2017, Scientific Reports.

GATA2 co-opts TGFβ1/SMAD4 oncogenic signaling and inherited variants at 6q22 to modulate prostate cancer progression

Qin Zhang, Gong-Hong Wei, A. Manninen, 2023, Journal of Experimental & Clinical Cancer Research.

An Inherited Allele Confers Prostate Cancer Progression and Drug Resistance via RFX6/HOXA10‐Orchestrated TGFβ Signaling

Qin Zhang, Mengjie Zhong, Yuehong Yang, 2024, Advanced science.